Variability and clinical relevance of the interaction between sodium valproate and carbamazepine in epileptic patients
- 1 May 1992
- journal article
- Published by Elsevier in Epilepsy Research
- Vol. 11 (3) , 193-198
- https://doi.org/10.1016/0920-1211(92)90098-e
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Medical assessment and treatment of chronic epilepsy.BMJ, 1991
- Established anticonvulsants and treatment of refractory epilepsyThe Lancet, 1990
- Carbamazepine-10,11-Epoxide in Epilepsy A Pilot StudyArchives of Neurology, 1990
- INHIBITION OF EPOXIDE HYDROLASE BY ANTICONVULSANTS AND RISK OF TERATOGENICITYThe Lancet, 1989
- ACUTE PSYCHOSIS WITH CARBAMAZEPINE AND SODIUM VALPROATEThe Lancet, 1989
- CLINICAL APPROACH TO THE MANAGEMENT OF INTRACTABLE EPILEPSYDevelopmental Medicine and Child Neurology, 1988
- Concentration-effect relationships with carbamazepine and its epoxide on psychomotor and cognitive function in epileptic patients.Journal of Neurology, Neurosurgery & Psychiatry, 1988
- Teratogenicity of Antiepileptic Drug Combinations with Special Emphasis on Epoxidation (of Carbamazepine)Epilepsia, 1984
- Carbamazepine 10, 11 epoxide concentrations in epileptics on carbamazepine alone and in combination with other anticonvulsants.British Journal of Clinical Pharmacology, 1983
- Factors Influencing Simultaneous Concentrations of Carbamazepine and Its Epoxide in PlasmaTherapeutic Drug Monitoring, 1981